| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.1B | $4.2B | $8.7B | $11.7B | $5.5B | $1.3B | $8.6B | $10.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.5B | $-0.8B | $3.1B | $3.8B | $0.9B | $0.2B | $-0.0B | $0.9B |
| Net Income | $1.8B | $-0.7B | $2.4B | $4.9B | $0.9B | $-0.4B | $-0.3B | $0.9B |
| EPS (Basic) | $7.67 | $-4.55 | $18.21 | $38.71 | $9.29 | $-42.54 | $-0.25 | $0.85 |
| EPS (Diluted) | $7.57 | $-4.55 | $16.92 | $33.36 | $8.12 | $-42.54 | $-0.25 | $0.85 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $28.3B | $27.9B | $14.4B | $15.5B | $11.0B | $6.6B | $16.2B | $10.9B |
| Current Assets | $2.9B | $2.0B | $2.6B | $2.7B | $2.1B | $1.1B | $1.3B | $1.6B |
| Cash & Equivalents | $0.6B | $0.3B | $1.1B | $0.1B | $0.9B | $0.3B | $0.0B | $0.0B |
| Total Liabilities | $9.7B | $10.3B | $3.6B | $6.3B | $5.3B | $11.9B | — | — |
| Current Liabilities | $2.9B | $3.1B | $1.3B | $2.7B | $2.4B | $3.1B | $2.4B | $2.8B |
| Stockholders' Equity | $18.6B | $17.6B | $10.7B | $9.1B | $5.7B | $-5.3B | $4.4B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.6B | $1.6B | $2.4B | $4.1B | $1.8B | $1.2B | $1.6B | $2.0B |
| Investing Cash Flow | $-2.8B | $-1.9B | $0.5B | $-3.4B | $-0.8B | $-1.0B | $-2.5B | $0.2B |
| Capital Expenditures | $2.7B | $1.6B | $1.8B | $1.8B | — | — | — | — |
| Financing Cash Flow | $-1.5B | $-0.4B | $-1.9B | $-1.4B | $-0.2B | $0.1B | $0.9B | $-2.2B |